TITRE III: Influenza B Immunogenicity Investigation
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 80
Summary
- Conditions
- Influenza
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 10 years and 13 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03753347
- Collaborators
- Vaccine Evaluation Center, Canada
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Institut National en Santé Publique du Québec
- Investigators
- Principal Investigator: Danuta M Skowronski, MD BC Centre for Disease Control